Dr. Reddy's Laboratories Limited (BOM: 500124)

Dr. Reddy's Laboratories Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	4,913	7,107	5,779	14,852	14,829	2,053
Short-Term Investments	89,713	74,363	56,018	29,513	19,744	23,687
Cash & Short-Term Investments	94,626	81,470	61,797	44,365	34,573	25,740
Cash Growth	57.03%	31.83%	39.29%	28.32%	34.32%	3.97%
Accounts Receivable	81,088	80,298	72,485	66,764	49,641	50,278
Other Receivables	-	2,908	1,451	5,051	4,815	7,031
Receivables	81,088	83,206	73,936	71,815	54,456	57,309
Inventory	68,568	63,552	48,670	50,884	45,412	35,066
Prepaid Expenses	-	1,947	1,452	1,138	1,141	950
Other Current Assets	24,906	17,874	18,398	13,654	12,667	11,305
Total Current Assets	269,188	248,049	204,253	181,856	148,249	130,370
Property, Plant & Equipment	80,343	76,886	66,462	62,169	57,111	52,332
Long-Term Investments	5,209	5,255	5,362	7,986	8,333	3,091
Goodwill	4,243	4,253	4,245	4,418	4,568	3,994
Other Intangible Assets	37,131	36,951	30,849	27,246	35,648	27,659
Long-Term Accounts Receivable	-	-	-	54	118	1,737
Long-Term Deferred Tax Assets	14,902	10,774	7,196	8,204	10,630	12,214
Other Long-Term Assets	4,281	5,350	3,487	894	834	844
Total Assets	415,297	387,518	321,854	292,827	265,491	232,241
Accounts Payable	34,109	21,547	17,857	15,971	12,696	10,745
Accrued Expenses	-	40,494	38,716	36,083	31,809	28,452
Short-Term Debt	23,165	12,723	7,390	27,082	23,145	16,532
Current Portion of Long-Term Debt	-	-	3,800	-	-	3,783
Current Portion of Leases	1,281	1,307	1,004	1,017	864	483
Current Income Taxes Payable	4,858	2,342	2,144	1,615	1,389	573
Current Unearned Revenue	-	1,435	1,981	2,576	2,033	1,910
Other Current Liabilities	42,260	16,191	12,953	9,671	11,455	10,336
Total Current Liabilities	105,673	96,039	85,845	94,015	83,391	72,814
Long-Term Debt	3,800	3,800	-	3,800	3,800	-
Long-Term Leases	2,429	2,190	1,278	1,946	2,499	1,304
Long-Term Unearned Revenue	-	1,193	1,555	1,597	1,531	1,956
Long-Term Deferred Tax Liabilities	4,785	909	833	60	338	275
Other Long-Term Liabilities	3,983	2,837	1,352	882	870	904
Total Liabilities	120,670	106,968	90,863	102,300	92,429	77,253
Common Stock	834	834	833	832	832	831
Additional Paid-In Capital	10,824	10,765	9,688	9,280	8,887	8,495
Retained Earnings	279,830	265,910	216,479	176,467	157,349	144,247
Treasury Stock	-972	-991	-1,269	-1,601	-1,967	-1,006
Comprensive Income & Other	4,111	4,032	5,260	5,549	7,961	2,421
Shareholders' Equity	294,627	280,550	230,991	190,527	173,062	154,988
Total Liabilities & Equity	415,297	387,518	321,854	292,827	265,491	232,241
Total Debt	30,675	20,020	13,472	33,845	30,308	22,102
Net Cash (Debt)	63,951	61,450	48,325	10,520	4,265	3,638
Net Cash Growth	33.96%	27.16%	359.36%	146.66%	17.23%	-
Net Cash Per Share	383.46	368.61	290.44	63.24	25.64	21.90
Filing Date Shares Outstanding	166.55	166.53	166.16	165.96	165.73	165.78
Total Common Shares Outstanding	166.55	166.53	166.16	165.96	165.73	165.78
Working Capital	163,515	152,010	118,408	87,841	64,858	57,556
Book Value Per Share	1769.05	1684.70	1390.20	1148.05	1044.27	934.92
Tangible Book Value	253,253	239,346	195,897	158,863	132,846	123,335
Tangible Book Value Per Share	1520.62	1437.27	1178.99	957.25	801.60	743.99
Land	-	4,224	4,234	4,154	4,147	4,045
Buildings	-	27,992	26,519	24,663	23,634	23,268
Machinery	-	117,082	107,205	95,100	85,470	81,450
Construction In Progress	-	14,462	9,956	13,305	9,778	4,521

Source: S&P Capital IQ. Standard template. Financial Sources.